In this region, APAC POCT device market is projected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024.
Based on geography, the APAC POCT market is segmented into 11 geographical regions, such as,
Japan,
China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest of APAC.
APAC POCT market competition by top players including -
F. Hoffmann La Roche Diagnostics Limited is dominating the APAC POCT device market major players followed by Abbott,
Alere Inc.,
Siemens AG,
Becton, Dickinson and Company,
Johnson & Johnson Services Inc.,
PTS Diagnostics,
Instrumentation Laboratory,
Nova Biomedical,
Beckman Coulter, Inc.,
Werfenlife
The APAC POCT device market is segmented on the basis of product type, prescription mode, distribution channel, end user, and geography.
The APAC POCT device market is segmented into twelve product types, such asblood glucose testing kits, cardio metabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing.
Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections, and respiratory infections testing kit.
Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
On the basis of prescription mode, the APAC point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the APAC point-of-care testing market is segmented into direct tenders and retail.
On the basis of end users, the APAC point-of-care testing market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.
TABLE OF CONTENTS
1. INTRODUCTION 17
1.1. OBJECTIVES OF THE STUDY 17
1.2. MARKET DEFINITION 17
1.3. OVERVIEW OF APAC POINT-OF-CARE TESTING MARKET 18
1.4. CURRENCY AND PRICING 19
1.5. LIMITATION 19
1.6. MARKETS COVERED 20
2. MARKET SEGMENTATION 22
2.1. MARKETS COVERED 22
2.2. GEOGRAPHIC SCOPE 23
2.3. YEARS CONSIDERED FOR THE STUDY 24
2.4. CURRENCY AND PRICING 24
2.5. RESEARCH METHODOLOGY 25
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.7. SECONDARY SOURCE 30
2.8. ASSUMPTIONS 30
3. MARKET OVERVIEW 31
3.1. DRIVERS 33
3.1.1. INCREASE IN CHRONIC AND INFECTIOUS DISEASES 33
3.1.2. ADVANCEMENT OF TECHNOLOGY 34
3.2. RESTRAINTS 35
3.2.1. RISING COST OF POCT TESTS 35
3.2.2. LOW REIMBURSEMENT SCENARIO 35
3.3. OPPORTUNITIES 36
3.3.1. SCOPE FOR UNMET MEDICAL NEEDS 36
3.3.2. EMERGING POCT DEVICE MARKET 36
3.4. THREATS 37
3.4.1. LACK OF ACCURACY AND THREATS 37
3.4.2. TESTING PERFORMED BY NON LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS 38
4. EXECUTIVE SUMMARY 39
5. PREMIUM INSIGHTS 42
6. APAC POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO 45
6.1. OVERVIEW 45
6.1.1. REGULATORY PROCEDURE: 45
6.2. CFDA 46
6.3. TGA 47
6.4. INDIA (CDSCO) 48
6.5. JAPAN (MHLW) 49
7. APAC POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO 51
7.1. OVERVIEW 51
8. APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE 52
8.1. OVERVIEW 53
8.2. CARDIOMETABOLIC MONITORING KITS 56
8.2.1. CARDIAC MARKERS 59
8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS 59
8.2.3. HBA1C TESTING KITS 60
8.2.4. LIPID TESTING KITS 60
8.3. INFECTIOUS DISEASE TESTING KITS 61
8.3.1. INFLUENZA TESTING KITS 64
8.3.2. HIV TESTING KITS 64
8.3.3. HEPATITIS TESTING KITS 65
8.3.4. STD TESTING KITS 65
8.3.5. TROPICAL DISEASES TESTING KITS 66
8.3.6. HEALTHCARE ASSOCIATED TESTING KITS 66
8.3.7. RESPIRATORY INFECTIONS TESTING KITS 67
8.4. CHOLESTEROL TESTING KITS 68
8.4.1. PROTHROMBIN TIME TESTING KITS 71
8.4.2. ACTIVATED CLOTTING TIME TESTING KITS 71
8.5. BLOOD GLUCOSE TESTING KITS 72
8.6. PREGNANCY AND FERTILITY TESTING KITS 74
8.7. TUMOR CANCER MARKERS 76
8.8. URINALYSIS TESTING KITS 78
8.9. HEMATOLOGY TESTING KITS 80
8.10. DRUGS OF ABUSE TESTING KITS 82
8.11. FECAL OCCULT TESTING KITS 84
8.12. RAPID COAGULATION TESTING KITS 85
9. APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL 87
9.1. OVERVIEW 88
9.1.1. DIRECT TENDER 90
9.1.2. RETAIL PHARMACY 92
10. APAC POINT-OF-CARE TESTING MARKET, BY END USER 94
10.1. OVERVIEW 95
10.2. APAC POCT MARKET: HOSPITALS 98
10.3. APAC POCT MARKET: CLINICS 101
10.4. APAC POCT MARKET: AMBULATORY CARE 103
10.5. APAC POCT MARKET: HOME HEALTHCARE 105
10.6. APAC POCT MARKET: RESEARCH LABORATORIES 107
11. APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 109
11.1. OVERVIEW 110
11.2. APAC POCT MARKET: PRESCRIPTION BASED TESTING KITS 112
11.3. APAC POCT MARKET: OVER THE COUNTER BASED TESTING KITS 115
12. APAC POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY 118
12.1. APAC POINT-OF-CARE TESTING MARKET 119
12.1.1. JAPAN POINT-OF-CARE TESTING MARKET 131
12.1.2. CHINA POINT-OF-CARE TESTING MARKET 135
12.1.3. SOUTH KOREA POINT-OF-CARE TESTING MARKET 139
12.1.4. INDIA POINT-OF-CARE TESTING MARKET 143
12.1.5. AUSTRALIA POINT-OF-CARE TESTING MARKET 147
12.1.6. SINGAPORE POINT-OF-CARE TESTING MARKET 151
12.1.7. THAILAND POINT-OF-CARE TESTING MARKET 155
12.1.8. MALAYSIA POINT-OF-CARE TESTING MARKET 159
12.1.9. INDONESIA POINT-OF-CARE TESTING MARKET 163
12.1.10. PHILIPPINES POINT-OF-CARE TESTING MARKET 167
12.1.11. REST OF APAC POINT-OF-CARE TESTING MARKET 171
12.2. COMPANY SHARE ANALYSIS: APAC 173
13. COMPANY PROFILES 174
13.1. JOHNSON AND JOHNSON SERVICES, INC. 174
13.1.1. COMPANY OVERVIEW 174
13.1.2. REVENUE ANALYSIS 175
13.1.3. PRODUCT PORTFOLIO 175
13.1.4. RECENT DEVELOPMENTS 175
13.2. BECTON, DICKINSON AND COMPANY 176
13.2.1. COMPANY OVERVIEW 176
13.2.2. REVENUE ANALYSIS 177
13.2.3. PRODUCT PORTFOLIO 177
13.2.4. RECENT DEVELOPMENTS 178
13.3. MEDTRONIC 179
13.3.1. COMPANY OVERVIEW 179
13.3.2. REVENUE ANALYSIS 180
13.3.3. PRODUCT PORTFOLIO 180
13.3.4. RECENT DEVELOPMENTS 181
13.4. F. HOFFMANN-LA ROCHE LTD 182
13.4.1. COMPANY OVERVIEW 182
13.4.2. REVENUE ANALYSIS 182
13.4.3. PRODUCT PORTFOLIO 183
13.4.4. RECENT DEVELOPMENTS 184
13.5. SIEMENS AG 185
13.5.1. COMPANY OVERVIEW 185
13.5.2. REVENUE ANALYSIS 185
13.5.3. PRODUCT PORTFOLIO 186
13.5.4. RECENT DEVELOPMENTS 187
13.6. ABBOTT 188
13.6.1. COMPANY OVERVIEW 188
13.6.2. REVENUE ANALYSIS 189
13.6.3. PRODUCT PORTFOLIO 189
13.6.4. PRODUCT PIPELINE 190
13.6.5. RECENT DEVELOPMENTS 191
13.7. DANAHER 192
13.7.1. COMPANY OVERVIEW 192
13.7.2. REVENUE ANALYSIS 193
13.7.3. PRODUCT PORTFOLIO 194
13.7.4. RECENT DEVELOPMENTS 194
13.8. WERFENLIFE 195
13.8.1. COMPANY OVERVIEW 195
13.8.2. REVENUE ANALYSIS 196
13.8.3. PRODUCT PORTFOLIO 197
13.8.4. RECENT DEVELOPMENTS 197
13.9. HENRY SCHEIN, INC. 198
13.9.1. COMPANY OVERVIEW 198
13.9.2. REVENUE ANALYSIS 199
13.9.3. PRODUCT PORTFOLIO 199
13.9.4. RECENT DEVELOPMENTS 201
13.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC) 202
13.10.1. COMPANY OVERVIEW 202
13.10.2. REVENUE ANALYSIS 203
13.10.3. PRODUCT PORTFOLIO 203
13.10.4. RECENT DEVELOPMENTS 204
13.11. SIENCO, INC. 205
13.11.1. COMPANY OVERVIEW 205
13.11.2. REVENUE ANALYSIS 205
13.11.3. PRODUCT PORTFOLIO 206
13.11.4. RECENT DEVELOPMENTS 206
13.12. ACON LABORATORIES, INC. 207
13.12.1. COMPANY OVERVIEW 207
13.12.2. REVENUE ANALYSIS 207
13.12.3. PRODUCT PORTFOLIO 208
13.12.4. RECENT DEVELOPMENTS 209
13.13. ATIVA MEDICAL CORPORATION 210
13.13.1. COMPANY OVERVIEW 210
13.13.2. REVENUE ANALYSIS 210
13.13.3. PRODUCT PORTFOLIO 211
13.13.4. RECENT DEVELOPMENTS 211
13.14. ABAXIS 212
13.14.1. COMPANY OVERVIEW 212
13.14.2. REVENUE ANALYSIS 213
13.14.3. PRODUCT PORTFOLIO 213
13.14.4. RECENT DEVELOPMENTS 214
13.15. ARKRAY, INC 215
13.15.1. COMPANY OVERVIEW 215
13.15.2. REVENUE ANALYSIS 215
13.15.3. PRODUCT PORTFOLIO 216
13.15.4. RECENT DEVELOPMENTS 216
13.16. AERSCHER DIAGNOSTICS, LLC 217
13.16.1. COMPANY OVERVIEW 217
13.16.2. REVENUE ANALYSIS 217
13.16.3. PRODUCT PORTFOLIO 218
13.16.4. RECENT DEVELOPMENTS 218
13.17. ARTRON LABORATORIES, INC. 219
13.17.1. COMPANY OVERVIEW 219
13.17.2. REVENUE ANALYSIS 219
13.17.3. PRODUCT PORTFOLIO 220
13.17.4. RECENT DEVELOPMENTS 222
13.18. BIOMERIEUX SA 223
13.18.1. COMPANY OVERVIEW 223
13.18.2. REVENUE ANALYSIS 224
13.18.3. PRODUCT PORTFOLIO 225
13.18.4. RECENT DEVELOPMENTS 225
13.19. ENTOPSIS 226
13.19.1. COMPANY OVERVIEW 226
13.19.2. REVENUE ANALYSIS 226
13.19.3. PRODUCT PORTFOLIO 227
13.19.4. RECENT DEVELOPMENTS 227
13.20. LIFESIGN, LLC. 228
13.20.1. COMPANY OVERVIEW 228
13.20.2. REVENUE ANALYSIS 228
13.20.3. PRODUCT PORTFOLIO 229
13.20.4. RECENT DEVELOPMENTS 229
14. RELATED REPORTS 230
TABLE LIST
TABLE 1 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES
TABLE 2 APAC POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3 APAC CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 4 APAC INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 5 APAC CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 6 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
TABLE 7 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 8 DISTRIBUTION CHANNEL, RETAIL PHARMACY, BY COUNTRIES 2015 – 2024 (USD MILLION)
TABLE 9 APAC POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 10 APAC POINT-OF-CARE TESTING MARKET, HOSPITALS, BY COUNTRIES 2015– 2024 (USD MILLION)
TABLE 11 APAC POINT-OF-CARE TESTING MARKET, CLINICS, BY COUNTRY 2015– 2024 (USD MILLION)
TABLE 12 APACPOINT-OF-CARE TESTING MARKET, AMBULATORY CARE, BY COUNTRY 2015– 2024 (USD MILLION)
TABLE 13 APAC POINT-OF-CARE TESTING MARKET, HOME HEALTHCARE, BY COUNTRY 2015– 2024 (USD MILLION)
TABLE 14 APAC POINT-OF-CARE TESTING MARKET, RESEARCH LABORATORY, BY COUNTRY 2015– 2024 (USD MILLION)
TABLE 15 APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015– 2024 (USD MILLION)
TABLE 16 APAC POINT-OF-CARE TESTING MARKET, PRESCRIPTION BASED TESTING KITS, BY COUNTRY, 2015– 2024 (USD MILLION)
TABLE 17 APAC POINT-OF-CARE TESTING MARKET, OVER THE COUNTER BASED TESTING KITS, BY COUNTRY, 2015– 2024 (USD MILLION)
TABLE 18 APAC POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 19 APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 20 APAC CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 21 APAC INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 22 APAC CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 23 APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 24 APAC POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 25 APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION)
TABLE 26 JAPAN POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 27 JAPAN POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 28 JAPAN POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 29 JAPAN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 30 CHINA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 31 CHINA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 32 CHINA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 33 CHINA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 34 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 35 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024(USD MILLION)
TABLE 36 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 37 SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 38 INDIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 39 INDIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 40 INDIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 41 INDIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 42 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 43 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 44 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 45 AUSTRALIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 46 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 47 SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 48 SINGAPORE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 49 SINGAPORE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 50 THAILAND POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 51 THAILAND POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 52 THAILAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 53 THAILAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 54 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 55 MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 56 MALAYSIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 57 MALAYSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 58 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 59 INDONESIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 60 INDONESIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 61 INDONESIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 62 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 63 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 64 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 65 PHILIPPINES POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 66 REST OF APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
FIGURES LIST
FIGURE 1 APAC POINT-OF-CARE TESTING MARKET: SEGMENTATION
FIGURE 2 APAC POINT-OF-CARE TESTING MARKET: GEOGRAPHIC SCOPE
FIGURE 3 APAC POINT-OF-CARE TESTING MARKET: DATA TRIANGULATION
FIGURE 4 APAC POINT-OF-CARE TESTING MARKET RESEARCH SNAPSHOT
FIGURE 5 APAC POINT-OF-CARE TESTING MARKET BOTTOM UP APPROACH
FIGURE 6 APAC POINT-OF-CARE TESTING MARKET TOP DOWN APPROACH
FIGURE 7 APAC POINT-OF-CARE TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE POINT-OF-CARE TESTING MARKET
FIGURE 9 APAC POINT-OF-CARE TESTING MARKET: SEGMENTATION
FIGURE 10 JAPAN IS EXPECTED TO DOMINATE THE MARKET FOR POINT-OF-CARE TESTINGAND CHINAIS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024
FIGURE 11 HIGH PREVALANCE OF BLOOD GLUCOSE ARE EXPECTED TO DRIVE THE MARKET FOR POINT-OF-CARE TESTING IN THE FORECAST PERIOD 2017 TO 2024
FIGURE 12 BLOOD GLUCOSE TESTING MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE POINT-OF-CARE TESTING MARKET IN 2017 & 2024
FIGURE 13 JAPAN IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR POINT-OF-CARE TESTING MANUFACTURERS IN THE FORECAST PERIOD TO 2024
FIGURE 14 APAC POINT-OF-CARE TESTING MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 15 APAC POCT MARKET: CARDIOMETABOLIC MONITORING KITS MARKET: BY PRODUCT SEGMENTATION
FIGURE 16 APAC POCT MARKET: INFECTIOUS DISEASE TESTING KITS MARKET: BY PRODUCT
FIGURE 17 APAC POCT MARKET: CHOLESTROL TESTING KITS MARKET: BY PRODUCT SEGMENTATION
FIGURE 18 APAC POCT MARKET: BLOOD GLUCOSE TESTING KITS MARKET: BY COUNTRIES
FIGURE 19 APAC POCT MARKET: PREGNANCY AND FERTILITY TESTING KITS MARKET: BY COUNTRIES
FIGURE 20 APACPOCT MARKET: TUMOR CANCER MARKERS MARKET: BY COUNTRIES
FIGURE 21 APAC POCT MARKET: URINALYSIS TESTING KITS MARKET: BY COUNTRIES
FIGURE 22 APAC POCT MARKET: HEMATOLOGY TESTING KITS MARKET: BY COUNTRIES
FIGURE 23 APAC POCT MARKET: DRUGS OF ABUSE TESTING KITS MARKET: BY COUNTRIES
FIGURE 24 APAC POCT MARKET: FECAL OCCULT TESTING KITS MARKET: BY REGION
FIGURE 25 APAC POCT MARKET: RAPID COAGULATION TESTING KITSMARKET: BY REGION
FIGURE 26 APAC POINT-OF-CARE TESTING MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 27 APAC POCT MARKET: DIRECT TENDER MARKET: BY REGION
FIGURE 28 RETAIL PHARMACY MARKET: BY COUNTRIES
FIGURE 29 APAC POINT-OF-CARE TESTING MARKET DOMINATED BY HOSPITALS SEGMENT
FIGURE 30 APAC POINT-OF-CARE TESTING MARKET:BY END-USER, SNAPSHOT 2016
FIGURE 31 APAC POCT MARKET: HOSPITALS; BY COUNTRIES
FIGURE 32 APAC POCT MARKET: CLINICS; BY COUNTRY
FIGURE 33 APAC POCT MARKET: AMBULATORY CARE; BY COUNTRY
FIGURE 34 APAC POCT MARKET: HOME HEALTHCARE; BY COUNTRY
FIGURE 35 APAC POCT MARKET: RESEARCH LABORATORY; BY COUNTRY
FIGURE 36 APAC POCT MARKET: PRESCRIPTION BASED TESTING KITS; BY COUNTRY
FIGURE 37 APAC POCT MARKET: OVER THE COUNTER BASED TESTING KITS; BY COUNTRY
FIGURE 38 APAC POINT-OF-CARE TESTING MARKET : SNAPSHOT (2017)
FIGURE 39 APAC POINT-OF-CARE TESTING MARKET : BY COUNTRY (2017)
FIGURE 40 APAC POINT-OF-CARE TESTING MARKET :BY PRODUCT TYPE (2016 & 2024)
FIGURE 41 APAC POINT-OF-CARE TESTING MARKET: COMPANY SHARE 2016 (%)
+1 888 709 8757
Chat With Us